Eledon Pharmaceuticals (ELDN) EPS (Weighted Average and Diluted) (2021 - 2026)
Eledon Pharmaceuticals (ELDN) reported EPS (Weighted Average and Diluted) of -$0.33 for Q1 2026, down 312.5% on a YoY basis from $0.16 in Q1 2025, and down 174.56% quarter-over-quarter from -$0.12 in Q4 2025.
Eledon Pharmaceuticals (ELDN) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Eledon Pharmaceuticals has reported EPS (Weighted Average and Diluted) for 6 years, with the latest figure at -$0.33 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 312.5% year-over-year to -$0.33; the trailing twelve-month figure through Mar 2026 stood at -$0.75 (up 98.53% YoY), and the FY2025 full-year result was -$0.52, up 31.04% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.33, down from -$0.12 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.48 in Q4 2024, with the low at -$51.29 in Q2 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$3.74 across 5 years, with a median of -$0.65 in 2022.
- The largest YoY upside for EPS (Weighted Average and Diluted) was 151.06% in 2024 against a maximum downside of 1771.9% in 2024.
- Eledon Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$4.09 in 2022, then surged by 77.02% to -$0.94 in 2023, then soared by 151.06% to $0.48 in 2024, then slumped by 125.04% to -$0.12 in 2025, then plunged by 174.56% to -$0.33 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.33 (Q1 2026), -$0.12 (Q4 2025), and -$0.21 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Eledon Pharmaceuticals | 439.58 Mn | 223.54 Mn | - | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -0.12 |
| Sep 30, 2025 | -0.21 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | 0.48 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -51.29 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.94 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -2.74 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -4.09 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.66 |
| Jun 30, 2021 | -0.50 |